Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID), 49609-49610 [2017-23336]

Download as PDF ethrower on DSK3G9T082PROD with NOTICES Federal Register / Vol. 82, No. 206 / Thursday, October 26, 2017 / Notices public comment period for the proposal by 30 days, so that the comment period ends on November 23, 2017. DATES: The proposed collection of information is amended effective October 18, 2017 and the public comment period shall terminate on November 23, 2017. FOR FURTHER INFORMATION CONTACT: A copy of the PRA OMB submission, including the proposed reporting form and instructions, supporting statement, and other documentation will be placed into OMB’s public docket files, once approved. These documents will also be made available on the Board’s public Web site at: https:// www.federalreserve.gov/apps/ reportforms/review.aspx or may be requested from the agency clearance officer, whose name appears below. Federal Reserve Board Clearance Officer—Nuha Elmaghrabi—Office of the Chief Data Officer, Board of Governors of the Federal Reserve System, Washington, DC 20551, (202) 452–3829. Telecommunications Device for the Deaf (TDD) users may contact (202) 263–4869, Board of Governors of the Federal Reserve System, Washington, DC 20551. SUPPLEMENTARY INFORMATION: On August 24, 2017, the Board invited public comment on a proposal that would extend for three years the FR Y–15 and make certain revisions to the report (FR Y–15 proposal). As revised, the report would include Mexican pesos in total payments activity rather than as a memorandum item; add securities brokers to the definition of financial institutions; expressly include derivative transactions where a clearing member bank guarantees the performance of a client to a central counterparty; and, specify how certain cleared derivatives transactions are reported.1 As initially proposed, these revisions to the FR Y–15 would have been effective for reports reflecting a December 31, 2017, as-of date. The comment period for the FR Y–15 proposal was previously scheduled to end on October 23, 2017. The Board has received feedback that additional time may be required for affected banking organizations to analyze the impact of, and to provide comments on, the FR Y–15 changes being proposed. In response to the feedback, this notice hereby reopens the public comment period for the FR Y–15 proposal by 30 days, with comments due November 23, 2017, to provide additional time for comment. 1 See 82 FR 40154 (August 24, 2017). VerDate Sep<11>2014 17:29 Oct 25, 2017 Jkt 244001 This notice also amends the proposed implementation date of the FR Y–15 proposal such that the proposed changes would be effective for reports reflecting the March 31, 2018, as-of date. This revision would provide respondents with an additional 90 days to prepare their systems to reflect any changes to the FR Y–15 that the Board may adopt after reviewing the comments received. Board of Governors of the Federal Reserve System, October 23, 2017. Ann E. Misback, Secretary of the Board. [FR Doc. 2017–23271 Filed 10–25–17; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Council for the Elimination of Tuberculosis Meeting Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Advisory Council for the Elimination of Tuberculosis (ACET). This meeting is open to the public, limited only by 100 room seating and 100 ports for audio phone lines. Time will be available for public comment. Comments should be submitted in writing by email to the contact person listed below. The deadline for receipt is Monday, December 4, 2017. Persons who desire to make an oral statement, may request it at the time of the public comment period on December 12, 2017 at 11:40 a.m. EST. This meeting is also accessible by teleconference: 1–877– 927–1433 and participant passcode: 12016435. DATES: The meeting will be held on December 11, 2017, 8:30 a.m. to 4:30 p.m., EST and December 12, 2017, 8:30 a.m. to 12:00 p.m., EST. ADDRESSES: CDC Corporate Square Campus, 8 Corporate Square Boulevard, Atlanta, Georgia 30329. FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee Management Specialist, CDC, 1600 Clifton Road NE., Mailstop: E–07, Atlanta, Georgia 30329, telephone (404) 639–8317; zkr7@cdc.gov. SUMMARY: PO 00000 Frm 00024 Fmt 4703 Sfmt 4703 49609 SUPPLEMENTARY INFORMATION: Purpose: This Council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis. Matters To Be Considered: The agenda will include discussions on (1) Update on preliminary tuberculosis funding formula; (2) Update on whole genome sequencing data sharing plan; (3) Update on three-month Isoniazid/ Rifapentine Regimen (3HP) guidelines; and (4) Updates from ACET workgroups. Agenda items are subject to change as priorities dictate. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2017–23335 Filed 10–25–17; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), announces the following meeting for the Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID). This meeting is open to the public, limited only by the space available; the meeting room will accommodate up to 100 people. The public is also welcome to listen to the meeting by telephone, limited only by the number of ports SUMMARY: E:\FR\FM\26OCN1.SGM 26OCN1 49610 Federal Register / Vol. 82, No. 206 / Thursday, October 26, 2017 / Notices available (50); the toll-free dial-in number is 1–877–951–7311, with a pass code of 2208740. The meeting will be held on December 6, 2017, 8:30 a.m. to 5:00 p.m., EST, and December 7, 2017, 8:30 a.m. to 12:00 p.m., EST. DATES: CDC, Global Communications Center, 1600 Clifton Road NE., Building 19, Auditorium B3, Atlanta, Georgia 30329; also 1–877– 951–7311, with a pass code of 2208740. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Robin Moseley, MAT, Designated Federal Officer, OID, CDC, 1600 Clifton Road NE., Mailstop D10, Atlanta, Georgia 30329, Telephone (404) 639– 4461; rrm1@cdc.gov. ethrower on DSK3G9T082PROD with NOTICES SUPPLEMENTARY INFORMATION: Purpose: The BSC, OID, provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, CDC; the Director, OID; and the Directors of the National Center for Immunization and Respiratory Diseases, the National Center for Emerging and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: Strategies, goals, and priorities for programs; research within the national centers; and overall strategic direction and focus of OID and the national centers. Matters To Be Considered: The agenda will include discussions on priority issues for the national centers, including foodborne infections, advanced molecular detection, antimicrobial resistance, sexually transmitted diseases, and vaccination coverage. A report back from the Board’s Food Safety Modernization Act Surveillance Working Group will also be given. Agenda items are subject to change as priorities dictate. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention . [FR Doc. 2017–23336 Filed 10–25–17; 8:45 am] BILLING CODE 4163–19–P VerDate Sep<11>2014 17:29 Oct 25, 2017 Jkt 244001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH); Meeting Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with section 10(a)(2) of the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), announces the following meeting of the Advisory Board on Radiation and Worker Health (ABRWH). This meeting is open to the public, limited only by the space available. The meeting space accommodates approximately 150 people. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcome to listen to the meeting by joining the teleconference at the USA toll-free, dial-in number at 1– 866–659–0537; the pass code is 9933701. The conference line has 150 ports for callers. The Web conference by which the public can view presentations as they are presented is https:// webconf.cdc.gov/zab6/yzdq02pl?sl=1. DATES: The meeting will be held on December 13 from 8:15 to 6:00 p.m. Mountain Time and December 14, 2017, 8:15 a.m. to 11:00 a.m. Mountain Time. A public comment session will begin on December 13 at 6:00 p.m. Mountain Time and conclude at 7:00 p.m. or following the final call for public comment, whichever comes first. ADDRESSES: Doubletree by Hilton Albuquerque, 201 Marquette Avenue Northwest, Albuquerque, New Mexico 87102; Phone: (505) 247–7057, Fax: (505) 247–7017. Audio conference call via FTS Conferencing. The USA toll-free dial-in number is 1–866–659–0537; the pass code is 9933701. Web conference by Skype: Meeting CONNECTION: https://webconf.cdc.gov/zab6/ yzdq02pl?sl=1. FOR FURTHER INFORMATION CONTACT: Theodore Katz, MPA, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E–20, Atlanta, Georgia 30333, Telephone (513) 533– 6800, Toll Free 1 (800) CDC–INFO, Email ocas@cdc.gov. SUMMARY: PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 SUPPLEMENTARY INFORMATION: Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, rechartered on March 22, 2016 pursuant to Executive Order 13708, and will expire on September 30, 2019. Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters to be Considered: The agenda will include discussions on: NIOSH Program Update; Department of Labor Program Update; Department of Energy Program Update; SEC Petitions Update; dose reconstruction review methods; review of methods for estimating coworker radiation doses; possible discussions of Site Profile reviews for Weldon Spring Plant (Weldon Spring, Missouri) and Pacific Proving Grounds (Marshall Islands); the SEC petition for Savannah River Site (1973–2007; Aiken, South Carolina), and possibly one or more of the following SEC petitions: Idaho National Laboratory (1963–1970; E:\FR\FM\26OCN1.SGM 26OCN1

Agencies

[Federal Register Volume 82, Number 206 (Thursday, October 26, 2017)]
[Notices]
[Pages 49609-49610]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-23336]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Office of Infectious Diseases 
(BSC, OID)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC), announces the 
following meeting for the Board of Scientific Counselors, Office of 
Infectious Diseases (BSC, OID). This meeting is open to the public, 
limited only by the space available; the meeting room will accommodate 
up to 100 people. The public is also welcome to listen to the meeting 
by telephone, limited only by the number of ports

[[Page 49610]]

available (50); the toll-free dial-in number is 1-877-951-7311, with a 
pass code of 2208740.

DATES: The meeting will be held on December 6, 2017, 8:30 a.m. to 5:00 
p.m., EST, and December 7, 2017, 8:30 a.m. to 12:00 p.m., EST.

ADDRESSES: CDC, Global Communications Center, 1600 Clifton Road NE., 
Building 19, Auditorium B3, Atlanta, Georgia 30329; also 1-877-951-
7311, with a pass code of 2208740.

FOR FURTHER INFORMATION CONTACT: Robin Moseley, MAT, Designated Federal 
Officer, OID, CDC, 1600 Clifton Road NE., Mailstop D10, Atlanta, 
Georgia 30329, Telephone (404) 639-4461; [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The BSC, OID, provides advice and guidance to the 
Secretary, Department of Health and Human Services; the Director, CDC; 
the Director, OID; and the Directors of the National Center for 
Immunization and Respiratory Diseases, the National Center for Emerging 
and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, 
Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: 
Strategies, goals, and priorities for programs; research within the 
national centers; and overall strategic direction and focus of OID and 
the national centers.
    Matters To Be Considered: The agenda will include discussions on 
priority issues for the national centers, including foodborne 
infections, advanced molecular detection, antimicrobial resistance, 
sexually transmitted diseases, and vaccination coverage. A report back 
from the Board's Food Safety Modernization Act Surveillance Working 
Group will also be given. Agenda items are subject to change as 
priorities dictate.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Claudette Grant
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention .
[FR Doc. 2017-23336 Filed 10-25-17; 8:45 am]
 BILLING CODE 4163-19-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.